Member Info for nashwan123

Bango looks oversold with today’s trading RNS including “ Adjusted EBITDA is expected to be at least $9.0M, up 34% (1H25: $6.7M), reflecting higher quality revenue and the FY25 efficiency initiatives. Cash EBITDA is expected to increase by at least $4.3M to $3.7M.”.

Looks to be more improvements to come!

Unless I am misreading the RNS then SSIT are carrying a £11M paper loss on this transaction.

Very straight bat employed against investor questions. The NDA re revenue from Croda is a negative for me. Also I didn’t leave feeling enthused that this company is progressing or actively looking to develop more revenue lines.she reiterated that although Axis might be having direct medical benefits for users the company cannot make such claims.

I sold a chunk at a thumping loss at 4.76p. Too much jam tomorrow from this board.

Just listened to Intercede presentation to investors. All good numbers as in public domain but key snippet is that they appear to have number one product to address the threat of quantum computing. They should pick up a much bigger market share going forward along with all countries needing to develop and secure their own sovereign cloud security too.

Several chunky £15k and £50k buys gone through this morning. LSE software still marks many as sells when in fact they re buys.

MMs have signalled they want shares today. Despite red on LSE trades many are buys. Gold price is up today too.

I was a holder here over 10 years ago and left after too many false dawns. I believe they are now on the cusp of significant growth that will see this share through the £1 mark.

I’d like to think this SP drop is to allow institutions in at a price they want to pay to meet their investment obligation now SSIT is a FTSE250 company.

I expect institutes buying as company is due to list on FTSE 250 this week!

Buyer beware. The purpose of the consolidation is to enable future fundraises.

I still have a Highlands Natural Resources hat given out on their trade stand. I suppose the common theme is oil and vapes create smoke.

Re the auditor is like a builder walking off a half finished job. Not many are prepared to come in and work through the mess left behind.it is often easier to start from scratch. Sadly for QDE this could be a long drawn out affair.

I’ve been a shareholder for over 15 years before Sisto took over. I attended several of their shareholder presentations. I remember asking Sisto ,why there was such a disconnect between the booked values of their portfolio and the share price?

He said once the portfolio developed the SP Would rise and shareholders would realise a good return.

As we have all witnessed it has been a continuous story of jam tomorrow with umpteen fund raises. I feel the game is finally up and yes if there was a better regulatory system then the doors may have been closed long ago. Another salutary lesson for suffering shareholders.

RPI down in line with IT sector but also announcing an overhang/dilution of thousands of heavily discounted shares.

I contacted the company today and had the courtesy of a reply noting my comments. Basically once an RNS is released re the outcome of the forensic report I have asked for “absolute clarity”.

The speculation that has abounded re the demise of Ashman and the Croda contract has not been healthy for shareholders, the company or the share price.

Croda final figures out tomorrow. Hopefully there will be a positive mention about Zenakine sales and buried away somewhere in the figures some royalties to SBTX. Surely they can’t play the NDA game too!

It’s 2026 and so called professional auditors are made to look like numpties. My experience in life is similar with conveyancing solicitors and surveyors. Take the money with minimus effort and no comeback. I’d be doing an Alan Sugar in the boardroom interrogation of these clowns. YOUR FIRED!

I hope we can trust the other directors and auditors that the figures released last year are to be trusted. Also the pre Xmas RNS

18 December 2025 - SkinBioTherapeutics plc (AIM: SBTX), a life science group focused on skin health, confirms that overall trading of the Group has started very positively for the new financial year. Consequently, the Board still anticipates reporting 2026 full year numbers in line with market expectations*.

Providing issue is with SA and not company figures then this should be a passing storm.

I believe it was also a code market makers used to indicate they wanted shares.